Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021 Biotech Investing
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS Annual Meeting Biotech Investing
BioNTech to Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD Biotech Investing
New Phase 3 Data Support the Sustained, Long-Acting Efficacy of Lenacapavir, Gilead's Investigational HIV-1 Capsid Inhibitor Biotech Investing
Four-Year Biktarvy® Data Presented at IAS 2021 Demonstrate High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults Biotech Investing
AbbVie Provides Update Regarding RINVOQ® for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S. Biotech Investing
Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck Biotech Investing
Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021 Biotech Investing
